CLDX
Price
$19.55
Change
-$0.12 (-0.61%)
Updated
Jun 5, 04:14 PM (EDT)
Capitalization
1.31B
63 days until earnings call
INVA
Price
$21.14
Change
+$0.26 (+1.25%)
Updated
Jun 5, 04:24 PM (EDT)
Capitalization
1.31B
55 days until earnings call
Interact to see
Advertisement

CLDX vs INVA

Header iconCLDX vs INVA Comparison
Open Charts CLDX vs INVABanner chart's image
Celldex Therapeutics
Price$19.55
Change-$0.12 (-0.61%)
Volume$1K
Capitalization1.31B
Innoviva
Price$21.14
Change+$0.26 (+1.25%)
Volume$100
Capitalization1.31B
CLDX vs INVA Comparison Chart
Loading...
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLDX vs. INVA commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDX is a Hold and INVA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (CLDX: $19.67 vs. INVA: $20.88)
Brand notoriety: CLDX and INVA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLDX: 76% vs. INVA: 169%
Market capitalization -- CLDX: $1.31B vs. INVA: $1.31B
CLDX [@Biotechnology] is valued at $1.31B. INVA’s [@Biotechnology] market capitalization is $1.31B. The market cap for tickers in the [@Biotechnology] industry ranges from $318.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDX’s FA Score shows that 0 FA rating(s) are green whileINVA’s FA Score has 1 green FA rating(s).

  • CLDX’s FA Score: 0 green, 5 red.
  • INVA’s FA Score: 1 green, 4 red.
According to our system of comparison, INVA is a better buy in the long-term than CLDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDX’s TA Score shows that 4 TA indicator(s) are bullish while INVA’s TA Score has 4 bullish TA indicator(s).

  • CLDX’s TA Score: 4 bullish, 5 bearish.
  • INVA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, INVA is a better buy in the short-term than CLDX.

Price Growth

CLDX (@Biotechnology) experienced а +5.41% price change this week, while INVA (@Biotechnology) price change was +9.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +9.95%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

CLDX is expected to report earnings on Aug 07, 2025.

INVA is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INVA($1.31B) and CLDX($1.31B) have the same market capitalization . INVA YTD gains are higher at: 20.346 vs. CLDX (-22.161). INVA has higher annual earnings (EBITDA): 681K vs. CLDX (-213.94M). CLDX has more cash in the bank: 673M vs. INVA (447M). CLDX has less debt than INVA: CLDX (3.43M) vs INVA (451M). INVA has higher revenues than CLDX: INVA (370M) vs CLDX (7.56M).
CLDXINVACLDX / INVA
Capitalization1.31B1.31B100%
EBITDA-213.94M681K-31,416%
Gain YTD-22.16120.346-109%
P/E RatioN/A51.97-
Revenue7.56M370M2%
Total Cash673M447M151%
Total Debt3.43M451M1%
FUNDAMENTALS RATINGS
CLDX vs INVA: Fundamental Ratings
CLDX
INVA
OUTLOOK RATING
1..100
424
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
75
Overvalued
PROFIT vs RISK RATING
1..100
6549
SMR RATING
1..100
9291
PRICE GROWTH RATING
1..100
8143
P/E GROWTH RATING
1..100
1002
SEASONALITY SCORE
1..100
9550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLDX's Valuation (54) in the Biotechnology industry is in the same range as INVA (75) in the Pharmaceuticals Other industry. This means that CLDX’s stock grew similarly to INVA’s over the last 12 months.

INVA's Profit vs Risk Rating (49) in the Pharmaceuticals Other industry is in the same range as CLDX (65) in the Biotechnology industry. This means that INVA’s stock grew similarly to CLDX’s over the last 12 months.

INVA's SMR Rating (91) in the Pharmaceuticals Other industry is in the same range as CLDX (92) in the Biotechnology industry. This means that INVA’s stock grew similarly to CLDX’s over the last 12 months.

INVA's Price Growth Rating (43) in the Pharmaceuticals Other industry is somewhat better than the same rating for CLDX (81) in the Biotechnology industry. This means that INVA’s stock grew somewhat faster than CLDX’s over the last 12 months.

INVA's P/E Growth Rating (2) in the Pharmaceuticals Other industry is significantly better than the same rating for CLDX (100) in the Biotechnology industry. This means that INVA’s stock grew significantly faster than CLDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLDXINVA
RSI
ODDS (%)
Bearish Trend 7 days ago
82%
Bearish Trend 2 days ago
69%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
66%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
72%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
63%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
62%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
64%
Advances
ODDS (%)
Bullish Trend 18 days ago
82%
Bullish Trend 2 days ago
67%
Declines
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 23 days ago
64%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
53%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RMYCX9.530.04
+0.42%
Russell Inv Multi-Strategy Income C
VEVIX44.98N/A
N/A
Victory Sycamore Established Value I
PAEEX20.70N/A
N/A
Putnam Dynamic Asset Allocation Gr R6
BIRIX21.59N/A
N/A
BlackRock Sustainable Adg Lg Cp Cr Instl
SREYX16.09N/A
N/A
SEI Real Estate Y (SIMT)

CLDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDX has been loosely correlated with BEAM. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDX
1D Price
Change %
CLDX100%
-1.01%
BEAM - CLDX
52%
Loosely correlated
+1.60%
DNLI - CLDX
49%
Loosely correlated
+3.52%
KYMR - CLDX
49%
Loosely correlated
+1.56%
RVMD - CLDX
49%
Loosely correlated
-0.49%
CRNX - CLDX
48%
Loosely correlated
+0.78%
More

INVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, INVA has been loosely correlated with CLDX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if INVA jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INVA
1D Price
Change %
INVA100%
+1.36%
CLDX - INVA
38%
Loosely correlated
-1.01%
GBIO - INVA
36%
Loosely correlated
-2.86%
DNLI - INVA
35%
Loosely correlated
+3.52%
INBX - INVA
35%
Loosely correlated
-3.92%
SLNO - INVA
35%
Loosely correlated
-0.45%
More